Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
81 participants
INTERVENTIONAL
2025-01-16
2025-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Isometric and Dynamic Handgrip Training Effects on Hypertension
NCT06601738
Isometric Training on Blood Pressure and on the Autonomic Modulation of Hypertensive Patients
NCT03216317
Effects of Life Style Intervention Manual in Pre Hypertensive Sedentary Population
NCT04841902
Comparison of Breathing Exercise for Hypertensive Patients
NCT05158569
Relaxation Breathing Exercises Effects Among Hypertensive Patients
NCT06131528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The group will not be provided with any interventions and would be used as controls.
No intervention
The subjects would not be given any intervention and would be used as controls.
Conventional Exercise Training
The subjects in the group would be doing treadmill training 3 days a week for 8 weeks (24 sessions) within target heart rate of moderate intensity.
Exercise
The subjects would be doing treadmill training within moderate intensity target heart rate.
Exergaming Training Group
The group would be doing exergaming 3 days a week for 8 weeks (24 sessions) within target heart rate of moderate intensity.
Exercise
The participants would be playing exergames using XBOX-360 Kinect. Multiple games would be selected for the participants to play. The player would be upgraded to next levels of games after completing the initial levels.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
The participants would be playing exergames using XBOX-360 Kinect. Multiple games would be selected for the participants to play. The player would be upgraded to next levels of games after completing the initial levels.
Exercise
The subjects would be doing treadmill training within moderate intensity target heart rate.
No intervention
The subjects would not be given any intervention and would be used as controls.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Any race or gender with age 20 or older
3. No history of any orthopedic, neurological, Pulmonary or psychological disorders, Cognitive impairments etc.
4. Had not performed physical activity in the previous three months.
Exclusion Criteria
2. Recent acute myocardial infarction; unstable angina; acute pericarditis. pulmonary hypertension; uncontrolled diabetes mellitus; Hypertensive crises or uncontrolled Hypertension or Pregnancy
3. Patients who had three consecutive absences during the intervention
4. Unable to answer or understand the gaming or exercise protocols and quality of life questionnaires and fulfil the exercise protocols, due to any severe cognitive deficit
5. Pain with ambulation or dizziness when standing or walking.
6. Contraindications to treadmill walking or VR gaming
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Imran Amjad, PhD
Role: PRINCIPAL_INVESTIGATOR
Riphah International University Islamabad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foundation University
Islamabad, Federal, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sana Bashir
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIPHAH/RCRS/REC/Letter-01198
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.